Standard Operating Procedure: G6PD Deficiency Screening (Quantitative/Qualitative)

This Standard Operating Procedure (SOP) outlines the clinical protocol for performing Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency screening. G6PD deficiency is a genetic condition that causes red blood cells to break down prematurely when exposed to certain medications, infections, or stressors. As an operations manager, it is critical that this procedure be followed with exact precision to prevent diagnostic errors, as misinterpretation can lead to the administration of contraindicated medications (e.g., primaquine, sulfonamides) that may trigger acute hemolytic anemia.

1. Pre-Analytical Phase: Patient Preparation and Specimen Collection

• Patient Verification: Verify patient identity using two unique identifiers (full name and DOB).
• Clinical History Review: Confirm if the patient has had a recent blood transfusion (within the last 3 months) or an acute hemolytic episode, as both can mask deficiency by causing a false-normal result.
• Phlebotomy: Collect whole blood via venipuncture into an EDTA (purple top) tube.
• Labeling: Ensure the specimen is labeled immediately at the bedside with the date, time, and collector’s initials.
• Transport: Maintain samples at 2–8°C. Do not freeze or expose to extreme heat. Process within 24 hours of collection for optimal accuracy.

2. Analytical Phase: Testing Procedure

• Instrument Calibration: Perform daily quality control (QC) as mandated by the manufacturer’s instructions. Ensure the optical path is clean and reagents are at room temperature if required.
• Sample Preparation: Gently invert the EDTA tube 8–10 times to ensure uniform cell distribution. Avoid vigorous shaking, which may cause hemolysis.
• Assay Execution:
  • Pipette the precise volume of whole blood into the reagent reaction cup/well.
  • Initiate the reaction according to the specific methodology (e.g., Kinetic UV assay or Fluorescent Spot Test).
  • Monitor the reaction timer; ensure the instrument maintains the required temperature (usually 37°C).
• Result Verification: Compare the results against the reference range programmed into the analyzer software.

3. Post-Analytical Phase: Data Entry and Reporting

• Review Results: Evaluate the raw data for internal consistency. If results are equivocal or fall in the "intermediate" range, request a repeat test or suggest genetic counseling/molecular testing.
• Documentation: Record the result, time, and technician ID in the Laboratory Information System (LIS).
• Flagging: Immediately notify the attending physician if the patient is scheduled for treatment with drugs known to induce hemolysis.

Pro Tips & Pitfalls

• The "False Normal" Pitfall: Never test a patient immediately following a hemolytic crisis. When G6PD-deficient cells are destroyed, the remaining red cells are often younger (reticulocytes), which have higher G6PD levels, potentially masking the deficiency. Wait 4–8 weeks post-crisis.
• Pro Tip on Reagents: Always check the lot-to-lot consistency. If switching reagent lots, perform a parallel run to ensure result stability.
• Temperature Control: Ensure your workspace is free of air drafts that could cause temperature fluctuations in the reaction chamber, as G6PD assays are highly temperature-sensitive.

Frequently Asked Questions (FAQ)

1. Can I use a capillary (finger-stick) sample? While some rapid point-of-care devices allow for capillary blood, venipuncture is preferred for quantitative spectrophotometric assays to ensure a consistent hematocrit level and accurate cell count.

2. What should I do if the control results fall outside the acceptable range? Stop testing immediately. Do not release any patient results. Troubleshoot the reagent lot, check the incubator temperature, and recalibrate the instrument. Document the failure in the QC logbook.

3. Why is the G6PD test sometimes called an "indirect" test? It is not an indirect test, but results can be "indirectly" affected by anemia. If a patient is severely anemic, the enzyme activity measurement may be artificially low. Always correlate the G6PD result with the patient’s complete blood count (CBC).